Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Pain 5Neoplasms 5Cancer Pain 2Neuralgia 1Chronic Pain 1Breast Neoplasms 1Agnosia 1

Interventions

Pregabalin 5Lidocaine 4Surveys and Questionnaires 3Bupivacaine 3ziconotide 2Transcranial Magnetic Stimulation 2Oxycodone 2Gabapentin 2Capsaicin 2Amitriptyline 2onabotulinum toxin A 1nabiximols 1Yoga 1Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Transcutaneous Electric Nerve Stimulation 1Thalidomide 1Telmisartan 1Tapentadol 1Spinal Cord Stimulation 1Sodium Chloride 1Saline Solution 1Radiofrequency Ablation 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Morphine 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuralgia × Tapentadol × Clear all
NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Completed
150 enrolled

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡